This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Mar;17(1):1-3.

doi: 10.1007/s11673-020-09980-z.

Cui Bono?

Michael Ashby¹, Bronwen Morrell²

Affiliations

Affiliations

¹ Cancer, Chronic Disease and Sub-Acute Stream, Royal Hobart Hospital, Tasmanian Health Service, Medical Ethics and Death Studies, School of Medicine, College of Health and Medicine, University of Tasmania, Repatriation Centre, 90 Davey Street, TAS, Hobart, 7000, Australia. michael.ashby@ths.tas.gov.au.
² Sydney Health Ethics, Level 1, Medical Foundation Building, K25, University of Sydney, Sydney, NSW, 2006, Australia.

PMID: 32458202
DOI: 10.1007/s11673-020-09980-z

Editorial

Cui Bono?

Michael Ashby et al. J Bioeth Inq. 2020 Mar.

. 2020 Mar;17(1):1-3.

doi: 10.1007/s11673-020-09980-z.

Authors

Michael Ashby¹, Bronwen Morrell²

Affiliations

¹ Cancer, Chronic Disease and Sub-Acute Stream, Royal Hobart Hospital, Tasmanian Health Service, Medical Ethics and Death Studies, School of Medicine, College of Health and Medicine, University of Tasmania, Repatriation Centre, 90 Davey Street, TAS, Hobart, 7000, Australia. michael.ashby@ths.tas.gov.au.
² Sydney Health Ethics, Level 1, Medical Foundation Building, K25, University of Sydney, Sydney, NSW, 2006, Australia.

PMID: 32458202
DOI: 10.1007/s11673-020-09980-z

No abstract available

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer